Todd C Brady

ALDX

Todd C Brady serves as director, officer: President and CEO at Aldeyra Therapeutics, Inc. (ALDX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$478.0K

Total Sells

2 trades

$1.11M

Net Position

Net Seller

$635.7K

Companies Traded

ALDX

Active Period

Jun 2022 – Jun 2026

4 total trades

Most Recent

Buy ALDX

Jun 5, 2026 · $418.4K

Todd C Brady's Insider Trading at Aldeyra Therapeutics, Inc. (ALDX)

Buys

2 · $478.0K

Sells

2 · $1.11M

Total Shares Bought

267,700

Total Shares Sold

257,045

ALDX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 5, 2026	Buy	250,000	$1.67	$418.4K	1,721,298
Mar 9, 2024	Sell	183,238	$3.17	$580.8K	0
Sep 7, 2023	Sell	73,807	$7.22	$532.9K	0
Jun 23, 2022	Buy	17,700	$3.36	$59.5K	0

Related Insiders

DOUGLAS RICHARD

director

ALDXBuy · Mar 20, 2026

Michael Alfieri

Principal Financial Officer

ALDXBuy · Mar 19, 2026

Stephen Machatha

Chief Development Officer

ALDXSell · Aug 11, 2025

Explore More Insider Trading Data

ALDX Insider Trading Activity

View all insider trades at Aldeyra Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity